[1] SHAH S, GOLDBERG DS. Acute-on-chronic liver failure: update on pathogenesis, therapeutic targets, predictive models, and liver transplantation[J]. Curr Opin Gastroenterol, 2021, 37(3): 173. doi: 10.1097/MOG.0000000000000722
[2] 向照, 杨晋辉. 肝衰竭患者非生物型人工肝治疗112例临床疗效[J]. 昆明医科大学学报, 2021, 42(12): 140.
[3] 董方红, 李平, 席佩佩, 等. 肝衰竭患者发生院内感染的相关因素分析[J]. 肝脏, 2021, 26(1): 75.
[4] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 实用肝脏病杂志, 2019, 22(2): 164. doi: 10.3969/j.issn.1672-5069.2019.02.004
[5] 中华人民共和国卫生部. 医院感染诊断标准(试行)[J]. 中华医学杂志, 2001, 81 (5): 314. doi: 10.3760/j:issn:0376-2491.2001.05.027
[6] 兰小勤, 纪雅丽, 陈金, 等. 基于MELD评分分层分析人工肝治疗对平台期肝衰竭患者短期预后的影响[J]. 临床肝胆病杂志, 2020, 36(9): 2005. doi: 10.3969/j.issn.1001-5256.2020.09.019
[7] MÜCKE MM, RUMYANTSEVA T, MÜCKE VT, et al. Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality[J]. Liver Int, 2018, 38(4): 645. doi: 10.1111/liv.13568
[8] 胡世芸, 吴洁姣, 杨雪松, 等. 肝衰竭医院感直接经济损失研究[J]. 中国感染控制杂志, 2019, 18(9): 859.
[9] 胡正翠, 陈怡. 慢加急性肝衰竭患者发生肺部感染的现状及影响因素研究[J]. 中华护理杂志, 2020, 55(10): 1521. doi: 10.3761/j.issn.0254-1769.2020.10.014
[10] 王宇, 许祥, 童晶晶, 等. 肝衰竭患者并发真菌感染病原学及影响因素[J]. 中华医院感染学杂志, 2020, 30(14): 2105.
[11] 贺新春, 唐世刚, 陈亮, 等. 乙型肝炎相关慢加急性肝衰竭患者医院侵袭性肺真菌病的临床研究[J]. 中国感染控制杂志, 2020, 19(8): 733.
[12] 范文瀚, 罗怡平, 廖威, 等. 肝衰竭合并真菌感染的易感因素及临床特点[J]. 肝脏, 2020, 25(4): 438.
[13] ZHANG X, YANG M, HU J, et al. Epidemiology of invasive pulmonary aspergillosis in patients with liver failure: clinical presentation, risk factors, and outcomes[J]. J Int Med Res, 2018, 46(2): 819.
[14] MATTOS AA, WILTGEN D, JOTZ RF, et al. Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis[J]. Ann Hepatol, 2020, 19(5): 451.
[15] MARCIANO S, DÍAZ JM, DIRCHWOLF M, et al. Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies[J]. Hepat Med, 2019, 11: 13.
[16] JAIN M, SANGLODKAR U, VENKATARAMAN J. Risk factors predicting nosocomial, healthcare-associated and community-acquired infection in spontaneous bacterial peritonitis and survival outcome[J]. Clin Exp Hepatol, 2019, 5(2): 133.
[17] 曹洋, 刘坤, 纪少博, 等. 老年住院患者医院感染影响因素与预警指标研究[J]. 中华医院感染学杂志, 2017, 27(8): 1879.
[18] 吴金凤, 程桂娥. 血液净化病人中心静脉置管感染的影响因素及病原菌分布[J]. 蚌埠医学院学报, 2018, 43(3): 413.
[19] 安彬彬, 饶素玉, 樊淑玉, 等. 肝衰竭患者人工肝置留管感染的病原学分布特征与相关细胞因子水平变化分析[J]. 浙江临床医学, 2017, 19(10): 1901.
[20] 肖玉福. 血糖水平对危重患者预后和感染的影响分析[J]. 青海医药杂志, 2019, 49(9): 8.
[21] BARTOLETTI M, BALDASSARRE M, DOMENICALI M, et al. Prognostic role of bacterial and fungal infections in patients with liver cirrhosis with and without acute-on-chronic liver failure: a prospective 2-center study[J]. Open Forum Infect Dis, 2020, 7(11): ofaa453.